A Differential Therapeutic Consideration for Use of Corticosteroids According to Established COVID-19 Clinical Phenotypes in Critically Ill Patients.
G. Moreno,M. Ruiz-Botella,I Martin-Loeches,J. Gomez Alvarez,M. Jimenez Herrera,M. Bodi,F. Armestar,A. Marques Parra,A. Estella,S. Trefler,R. Jorge Garcia,J. Murcia Paya,P. Vidal Cortes,E. Diaz,R. Ferrer,A. Albaya-Moreno, L. Socias-Crespi,J. M. Bonell Goytisolo,S. Sancho Chinesta,A. Loza, L. Forcelledo Espina,J. C. Pozo Laderas,M. DeAlba-Aparicio,L. Sanchez Montori,I Vallverdu Perapoch,V Hidalgo,V Fraile Gutierrez, A. M. Casamitjana Ortega, F. Martin Serrano,M. Nieto, M. Blasco Cortes,J. Marin-Corral,J. Sole-Violan,A. Rodriguez MEDICINA INTENSIVA（2023）
关键词
COVID-19,Corticosteroids,Phenotypes,ICU mortality,SARS-CoV2-pneumonia,Unsupervised clustering
AI 理解论文
溯源树
样例
